Growth Metrics

Volitionrx (VNRX) Income from Continuing Operations (2019 - 2025)

Volitionrx's Income from Continuing Operations history spans 9 years, with the latest figure at 260595.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 49.54% year-over-year to 260595.0; the TTM value through Dec 2025 reached 5262408.0, up 32.81%, while the annual FY2025 figure was 146302.0, 49.58% down from the prior year.
  • Income from Continuing Operations reached 260595.0 in Q4 2025 per VNRX's latest filing, up from 31433.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 516444.0 in Q4 2024 to a low of 9521927.0 in Q2 2023.
  • Average Income from Continuing Operations over 5 years is 2424190.65, with a median of 37528.5 recorded in 2021.
  • Peak YoY movement for Income from Continuing Operations: soared 791.1% in 2022, then tumbled 12585.14% in 2023.
  • A 5-year view of Income from Continuing Operations shows it stood at 73088.0 in 2021, then grew by 28.74% to 94092.0 in 2022, then plummeted by 9380.53% to 8732237.0 in 2023, then soared by 105.91% to 516444.0 in 2024, then tumbled by 49.54% to 260595.0 in 2025.
  • Per Business Quant, the three most recent readings for VNRX's Income from Continuing Operations are 260595.0 (Q4 2025), 31433.0 (Q3 2025), and 29992.0 (Q2 2025).